LPL Financial LLC

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 1403438 FORT MILL, SC

Position in RCKT

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,100,679

+$541,892 QoQ

Shares Held

321,836

+106.2% QoQ

Ownership

0.293%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#40

of 180 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

LPL Financial LLC holds $551,304,275 across 203 Biotechnology names. RCKT ranks #59 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	289,111	$143,610,107
2	REGN	Regeneron Pharmaceuticals, Inc.	65,755	$41,000,872
3	ARWR	Arrowhead Pharmaceuticals, Inc.	310,761	$25,330,129
4	ARGX	Argenx SE	19,499	$18,090,587
5	ALNY	Alnylam Pharmaceuticals, Inc.	57,890	$17,426,626
6	HALO	Halozyme Therapeutics, Inc.	203,557	$15,932,406
7	RPRX	Royalty Pharma plc	249,117	$13,967,990
8	INSM	INSMED Inc	128,553	$13,706,320

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,100,679	321,836	+106.2%	Shares	Sole	2026-08-07
2026-03-31	$558,787	156,086	+65.6%	Shares	Sole	2026-05-06
2025-12-31	$330,838	94,256	+628.6%	Shares	Sole	2026-02-11
2025-09-30	$42,171	12,936	+15.6%	Shares	Sole	2025-11-12
2025-06-30	$27,405	11,186	-23.2%	Shares	Sole	2025-08-12
2025-03-31	$97,168	14,568	+41.5%	Shares	Sole	2025-05-07
2024-12-31	$129,383	10,293	-1.0%	Shares	Sole	2025-02-11
2024-09-30	$191,958	10,393	-0.8%	Shares	Sole	2024-11-08
2024-06-30	$225,612	10,479	+14.1%	Shares	Sole	2024-08-07
2024-03-31	$247,363	9,182	-10.3%	Shares	Sole	2024-05-10
2023-12-31	$306,653	10,232	-5.0%	Shares	Sole	2024-02-14
2023-09-30	$220,595	10,766	-9.8%	Shares	Sole	2023-11-13
2023-06-30	$237,267	11,941	-9.8%	Shares	Sole	2023-07-31
2023-03-31	$226,818	13,241	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.